Hepatitis B virus — Drug Target

All drugs that target Hepatitis B virus — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Antiviral

Phase 2 pipeline (1)

• ARB-001467 · Arbutus Biopharma Corporation · Antiviral · Infectious Diseases
  ARB-001467 is an investigational drug that targets the hepatitis B virus.